CALLIE CURTIS: Open Payments
NPI 1952009052 · BENTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 69 payments from 11 companies in 2025. Trend: 2023 $439 · 2024 $891 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $260 |
| ABBVIE INC. | 13 | $229 |
| AstraZeneca Pharmaceuticals LP | 10 | $200 |
| Lilly USA, LLC | 13 | $135 |
| Dexcom, Inc. | 4 | $72 |
| Antares Pharma, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Alkermes, Inc. | 1 | $24 |
Products named: NURTEC ODT, UBRELVY, PREVNAR 20, BREZTRI, QULIPTA, Dexcom G6 Transmitter, JARDIANCE, FARXIGA.
Industry payments across AR — which companies pay providers there.
